Prader-Willi syndrome (PWS) is a rare genetic condition that affects roughly 1 in 10,000 to 25,000 people, depending on the population studied. It causes a distinctive pattern of symptoms that shifts dramatically over a person’s lifetime: severe low muscle tone and feeding difficulties in infancy, followed by an unrelenting, insatiable hunger that typically begins in early childhood and persists for life. Without careful management, this drive to eat leads to dangerous obesity and a range of serious health complications.
What Causes Prader-Willi Syndrome
PWS stems from a problem on chromosome 15. Everyone inherits two copies of this chromosome, one from each parent. Certain genes on chromosome 15 only function when they come from the father’s copy. The mother’s version of these same genes is naturally silenced through a process called genomic imprinting. PWS happens when the father’s active copies are missing or nonfunctional, leaving no working version of these genes at all.
About 70% of cases occur because a segment of the father’s chromosome 15 is physically deleted. In another 25% of cases, the child inherits two copies of chromosome 15 from the mother and none from the father, a situation called maternal uniparental disomy. The remaining cases involve rare chromosomal rearrangements or other changes that silence the paternal genes. None of these genetic events are typically inherited from a parent in a predictable pattern, meaning most cases arise spontaneously.
How Symptoms Change From Infancy to Childhood
The earliest and most recognizable sign is severe floppiness (hypotonia) at birth. Newborns with PWS have extremely weak muscle tone, which makes feeding difficult. Many struggle to breastfeed or bottle-feed and may need specialized support to get enough nutrition. Failure to thrive is common in the first months of life, and some infants require tube feeding.
Motor milestones come late. Children with PWS typically sit around 12 months and walk around 24 months. Between ages 1 and 6, the condition takes its most dramatic turn: the feeding difficulties reverse into hyperphagia, an overwhelming, persistent drive to eat. Weight gain accelerates rapidly, and without strict external controls on food access, obesity develops quickly. This transition from a baby who can barely eat to a child who cannot stop eating is one of the most distinctive features of the condition.
Why the Hunger Is So Intense
The hyperphagia in PWS is not a matter of willpower or poor habits. It is driven by measurable hormonal imbalances. Ghrelin, the hormone that signals hunger, runs about 75% higher in children with PWS compared to other children with obesity. At the same time, the hormones that normally tell the brain “you’ve eaten enough” respond sluggishly. After a high-fat meal, for example, the fullness signal from the gut is delayed and blunted in PWS.
The ratio between hunger-promoting and fullness-promoting hormones stays elevated even after meals, meaning the biological drive to eat rarely switches off. On top of this, people with PWS can consume up to three times the amount of food a typical person would eat in one sitting, despite having slower gastric emptying. The brain simply does not receive the message to stop. This makes environmental controls, like locked kitchens and structured meal plans, a medical necessity rather than a lifestyle choice.
Behavioral Characteristics Beyond Hunger
PWS produces a recognizable behavioral profile that extends well beyond food-seeking. Skin picking is one of the most common features, reported in 55% to nearly 100% of individuals depending on the study. It typically starts after age 2 and often targets the arms, legs, hands, and feet. The behavior frequently begins at the site of a minor irritation like an insect bite and is most likely to occur when a person is alone, bored, or anxious. It can cause significant tissue damage and infection if not managed.
Temper outbursts are another hallmark, often triggered by changes in routine or denied access to food. People with PWS tend to have a strong insistence on sameness in daily activities and social contexts, independent of their cognitive level. Repetitive questioning, hoarding, and mood fluctuations occur at higher rates than in other populations with intellectual disability. Anxiety is common, and in adolescence and adulthood, some individuals develop psychotic episodes, particularly those whose PWS was caused by maternal uniparental disomy rather than deletion.
Medical Complications
Obesity is the most dangerous consequence of unmanaged hyperphagia and drives many of the life-threatening complications. But even without severe obesity, the underlying features of PWS create independent health risks.
Respiratory problems are the leading cause of death at all ages. The combination of low muscle tone, abnormal breathing responses during sleep, scoliosis, and obesity creates a perfect storm for breathing difficulties. Obstructive sleep apnea, central sleep apnea, and nighttime hypoventilation are all common. Some individuals experience silent aspiration, where food or liquid enters the airway without obvious coughing, leading to recurrent chest infections. Respiratory causes account for more than half of all deaths in people with PWS.
Other frequent complications include scoliosis, type 2 diabetes, and hormonal deficiencies. Most individuals have some degree of growth hormone deficiency, which contributes to short stature, low muscle mass, and increased body fat even before obesity becomes a factor. Hypogonadism (underproduction of sex hormones) is nearly universal, leading to incomplete puberty and infertility in most cases.
How It Is Diagnosed
Genetic testing is the definitive way to confirm PWS. The preferred first-line test is a DNA methylation analysis, which detects the characteristic pattern of gene silencing on chromosome 15. This test picks up more than 99% of cases regardless of the underlying genetic mechanism, making it highly reliable. If methylation testing is positive, additional tests can determine whether the cause is a deletion, uniparental disomy, or an imprinting defect, which matters for genetic counseling and for anticipating certain behavioral risks.
In practice, testing is usually prompted by the combination of severe neonatal hypotonia and feeding difficulties. Earlier diagnosis has become more common, which allows families to prepare for the nutritional transition and begin interventions sooner.
Growth Hormone Therapy and Its Effects
Growth hormone therapy is one of the most impactful treatments available for PWS and is now standard care starting in infancy or early childhood. In clinical trials, treated children showed a 6.5 percentage point reduction in body fat compared to untreated children, along with a gain of roughly 4.3 kilograms of lean muscle mass. These are not cosmetic changes. Improved muscle mass translates into better motor function, greater physical endurance, and stronger respiratory muscles.
The benefits appear strongest when treatment starts early. Studies show the greatest improvements in motor development and muscle strength during the first years of therapy and at younger ages. Growth hormone also increases height, improves bone density, and may support cognitive development, though the evidence for cognitive effects is less definitive. One notable metabolic effect is improved insulin sensitivity, which helps offset the diabetes risk that comes with the condition.
Daily Life and Long-Term Outlook
Managing PWS is a lifelong effort centered on controlling food access and supporting physical, behavioral, and emotional health. Families typically need to secure food storage areas, maintain strict mealtime routines, and coordinate with schools and caregivers to prevent unsupervised eating. Caloric needs are lower than average because of reduced muscle mass and a slower metabolic rate, so even moderate overeating leads to rapid weight gain.
Intellectual disability is present in most cases, usually in the mild to moderate range, and most adults need some level of supervised living. With comprehensive care, including growth hormone therapy, dietary management, behavioral support, and monitoring for respiratory and metabolic complications, quality of life has improved substantially over the past few decades. However, life expectancy remains significantly shortened. A large French study tracking deaths over 11 years found the median age at death was 30 years, with respiratory failure as the primary cause. Among adults who died, 98% were obese, underscoring how critical weight management is to survival. The range was wide, though, with some individuals living into their late 50s, particularly those who had access to structured care environments throughout their lives.